Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ippoliti

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Digestive Diseases and Sciences|October 6, 2015
Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's ColitisSasha Taleban, Martijn G H Van Oijen, Eric A Vasiliauskas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2007
Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control studyGil Y Melmed, Robert Elashoff, Gary C Chen, et al.
Gastroenterology|January 1, 1992
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter StudyS J Sontag, B I Hirschowitz, S Holt, et al.
Neurotoxicity Research|April 23, 2013
Altered cytokine and BDNF levels in autism spectrum disorderS Ricci, R Businaro, F Ippoliti, et al.
The American Journal of Gastroenterology|July 5, 2006
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnessesGil Y Melmed, Andrew F Ippoliti, Konstantinos A Papadakis, et al.
The American Journal of Gastroenterology|September 17, 2009
Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel diseaseGil Y Melmed, Nik Agarwal, Robert W Frenck, et al.
The New England Journal of Medicine|June 2, 1983
Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trialJ I Isenberg, W L Peterson, J D Elashoff, et al.
Panminerva Medica|February 12, 1999
Different reactivity against HCV proteins (RIBA 3) according to progression of liver damageI G Barbacini, E Goldoni, G M De Sanctis, et al.
Gastroenterology|February 1, 1978
Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trialA F Ippoliti, R A Sturdevant, J I Isenberg, et al.
Nature Genetics|April 17, 2007
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesisJohn D Rioux, Ramnik J Xavier, Kent D Taylor, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Digestive Diseases and Sciences|October 6, 2015
Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's ColitisSasha Taleban, Martijn G H Van Oijen, Eric A Vasiliauskas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2007
Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control studyGil Y Melmed, Robert Elashoff, Gary C Chen, et al.
Gastroenterology|January 1, 1992
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter StudyS J Sontag, B I Hirschowitz, S Holt, et al.
Neurotoxicity Research|April 23, 2013
Altered cytokine and BDNF levels in autism spectrum disorderS Ricci, R Businaro, F Ippoliti, et al.
The American Journal of Gastroenterology|July 5, 2006
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnessesGil Y Melmed, Andrew F Ippoliti, Konstantinos A Papadakis, et al.
The American Journal of Gastroenterology|September 17, 2009
Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel diseaseGil Y Melmed, Nik Agarwal, Robert W Frenck, et al.
The New England Journal of Medicine|June 2, 1983
Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trialJ I Isenberg, W L Peterson, J D Elashoff, et al.
Panminerva Medica|February 12, 1999
Different reactivity against HCV proteins (RIBA 3) according to progression of liver damageI G Barbacini, E Goldoni, G M De Sanctis, et al.
Gastroenterology|February 1, 1978
Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trialA F Ippoliti, R A Sturdevant, J I Isenberg, et al.
Nature Genetics|April 17, 2007
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesisJohn D Rioux, Ramnik J Xavier, Kent D Taylor, et al.
Pageof 6